UW Health and the UW School of Medicine and Public Health are announcing the formation of the University of Wisconsin Clinical Trials Institute to advance health care innovations via clinical trials at UW–Madison. The institute serves as a centralized hub focused on...
With these results, Breyanzi has now demonstrated clinically meaningful benefit across the broadest array of B-cell malignancies of any CD19-directed CAR T cell therapy, underscoring the company’s leadership in advancing innovative therapies for many types of...
By: Lisa Johnson In this In Business article, Lisa Johson, Bioforward’s CEO, talks about how the U.S. government’s CHIPS and Science Act is planning to give $10 billion dollars to six regional innovation and technology hubs across the country, and the...
We’re thrilled to share the news — Cytiva and the Life Sciences business of Pall have united under the Cytiva name! With a mission to advance therapeutics from discovery to delivery, combining our organizations just makes sense. Together, we bring broad and deep...
In an advance they consider a breakthrough in computational chemistry research, University of Wisconsin–Madison chemical engineers have developed a model of how catalytic reactions work at the atomic scale. This understanding could allow engineers and chemists to...